Hyperbaric oxygen: A useful adjunct for purpura fulminans Case report and review of the literature

Jeffrey S Cooper, Peter Allinson, Lon Keim, Joseph Harold Sisson, Dan Schuller, Joe Sippel, David H. Kovaleski, M. D. Fasn

Research output: Contribution to journalArticle

4 Citations (Scopus)

Abstract

Introduction: We report a case of a previously healthy adult with flulike symptoms who precipitously declined due to pneumococcal sepsis complicated by disseminated intravascular coagulation (DIC) and purpura fulminans (PF). After one week of care, including ventilation support and hemodialysis, the patient was stable enough for hyperbaric oxygen (HBO2) in an attempt to salvage his threatened extremities. HBO2 resulted in reduction of ischemic tissue and demarcation of blackened tissue to the distal digits. We feel that much at-risk tissue has been spared by HBO2 as an adjunctive therapy. Methods: Literature on the use of hyperbaric oxygen for purpura fulminans was reviewed for precipitating issues, time to treatment, protocol, other adjuncts and outcomes. Results: Fifteen papers were identified representing 19 cases of PF treated with HBO2. No controlled studies exist. HBO2 was believed to be of value in most cases; the improvement was associated with timeliness and aggressiveness of initiating HBO2. Conclusions: PF is a fulminant disorder with high mortality and morbidity. Hyperbaric oxygen appears to be useful for the management of PF complications, imposing minimal side effects or complications. Aggressive therapy should be started as soon as it is safe to transfer the patient to a facility for HBO2 treatments.

Original languageEnglish (US)
Pages (from-to)51-57
Number of pages7
JournalUndersea and Hyperbaric Medicine
Volume41
Issue number1
StatePublished - Jan 1 2014

Fingerprint

Purpura Fulminans
Oxygen
Patient Transfer
Disseminated Intravascular Coagulation
Clinical Protocols
Ventilation
Renal Dialysis
Sepsis
Therapeutics
Extremities
Morbidity
Mortality

ASJC Scopus subject areas

  • Pulmonary and Respiratory Medicine
  • Physiology (medical)

Cite this

Hyperbaric oxygen : A useful adjunct for purpura fulminans Case report and review of the literature. / Cooper, Jeffrey S; Allinson, Peter; Keim, Lon; Sisson, Joseph Harold; Schuller, Dan; Sippel, Joe; Kovaleski, David H.; Fasn, M. D.

In: Undersea and Hyperbaric Medicine, Vol. 41, No. 1, 01.01.2014, p. 51-57.

Research output: Contribution to journalArticle

Cooper, JS, Allinson, P, Keim, L, Sisson, JH, Schuller, D, Sippel, J, Kovaleski, DH & Fasn, MD 2014, 'Hyperbaric oxygen: A useful adjunct for purpura fulminans Case report and review of the literature', Undersea and Hyperbaric Medicine, vol. 41, no. 1, pp. 51-57.
Cooper, Jeffrey S ; Allinson, Peter ; Keim, Lon ; Sisson, Joseph Harold ; Schuller, Dan ; Sippel, Joe ; Kovaleski, David H. ; Fasn, M. D. / Hyperbaric oxygen : A useful adjunct for purpura fulminans Case report and review of the literature. In: Undersea and Hyperbaric Medicine. 2014 ; Vol. 41, No. 1. pp. 51-57.
@article{2e915a48503944aa969e151af7495b7f,
title = "Hyperbaric oxygen: A useful adjunct for purpura fulminans Case report and review of the literature",
abstract = "Introduction: We report a case of a previously healthy adult with flulike symptoms who precipitously declined due to pneumococcal sepsis complicated by disseminated intravascular coagulation (DIC) and purpura fulminans (PF). After one week of care, including ventilation support and hemodialysis, the patient was stable enough for hyperbaric oxygen (HBO2) in an attempt to salvage his threatened extremities. HBO2 resulted in reduction of ischemic tissue and demarcation of blackened tissue to the distal digits. We feel that much at-risk tissue has been spared by HBO2 as an adjunctive therapy. Methods: Literature on the use of hyperbaric oxygen for purpura fulminans was reviewed for precipitating issues, time to treatment, protocol, other adjuncts and outcomes. Results: Fifteen papers were identified representing 19 cases of PF treated with HBO2. No controlled studies exist. HBO2 was believed to be of value in most cases; the improvement was associated with timeliness and aggressiveness of initiating HBO2. Conclusions: PF is a fulminant disorder with high mortality and morbidity. Hyperbaric oxygen appears to be useful for the management of PF complications, imposing minimal side effects or complications. Aggressive therapy should be started as soon as it is safe to transfer the patient to a facility for HBO2 treatments.",
author = "Cooper, {Jeffrey S} and Peter Allinson and Lon Keim and Sisson, {Joseph Harold} and Dan Schuller and Joe Sippel and Kovaleski, {David H.} and Fasn, {M. D.}",
year = "2014",
month = "1",
day = "1",
language = "English (US)",
volume = "41",
pages = "51--57",
journal = "Undersea and Hyperbaric Medicine",
issn = "1066-2936",
publisher = "Undersea and Hyperbaric Medical Society",
number = "1",

}

TY - JOUR

T1 - Hyperbaric oxygen

T2 - A useful adjunct for purpura fulminans Case report and review of the literature

AU - Cooper, Jeffrey S

AU - Allinson, Peter

AU - Keim, Lon

AU - Sisson, Joseph Harold

AU - Schuller, Dan

AU - Sippel, Joe

AU - Kovaleski, David H.

AU - Fasn, M. D.

PY - 2014/1/1

Y1 - 2014/1/1

N2 - Introduction: We report a case of a previously healthy adult with flulike symptoms who precipitously declined due to pneumococcal sepsis complicated by disseminated intravascular coagulation (DIC) and purpura fulminans (PF). After one week of care, including ventilation support and hemodialysis, the patient was stable enough for hyperbaric oxygen (HBO2) in an attempt to salvage his threatened extremities. HBO2 resulted in reduction of ischemic tissue and demarcation of blackened tissue to the distal digits. We feel that much at-risk tissue has been spared by HBO2 as an adjunctive therapy. Methods: Literature on the use of hyperbaric oxygen for purpura fulminans was reviewed for precipitating issues, time to treatment, protocol, other adjuncts and outcomes. Results: Fifteen papers were identified representing 19 cases of PF treated with HBO2. No controlled studies exist. HBO2 was believed to be of value in most cases; the improvement was associated with timeliness and aggressiveness of initiating HBO2. Conclusions: PF is a fulminant disorder with high mortality and morbidity. Hyperbaric oxygen appears to be useful for the management of PF complications, imposing minimal side effects or complications. Aggressive therapy should be started as soon as it is safe to transfer the patient to a facility for HBO2 treatments.

AB - Introduction: We report a case of a previously healthy adult with flulike symptoms who precipitously declined due to pneumococcal sepsis complicated by disseminated intravascular coagulation (DIC) and purpura fulminans (PF). After one week of care, including ventilation support and hemodialysis, the patient was stable enough for hyperbaric oxygen (HBO2) in an attempt to salvage his threatened extremities. HBO2 resulted in reduction of ischemic tissue and demarcation of blackened tissue to the distal digits. We feel that much at-risk tissue has been spared by HBO2 as an adjunctive therapy. Methods: Literature on the use of hyperbaric oxygen for purpura fulminans was reviewed for precipitating issues, time to treatment, protocol, other adjuncts and outcomes. Results: Fifteen papers were identified representing 19 cases of PF treated with HBO2. No controlled studies exist. HBO2 was believed to be of value in most cases; the improvement was associated with timeliness and aggressiveness of initiating HBO2. Conclusions: PF is a fulminant disorder with high mortality and morbidity. Hyperbaric oxygen appears to be useful for the management of PF complications, imposing minimal side effects or complications. Aggressive therapy should be started as soon as it is safe to transfer the patient to a facility for HBO2 treatments.

UR - http://www.scopus.com/inward/record.url?scp=84894499797&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84894499797&partnerID=8YFLogxK

M3 - Article

C2 - 24649717

AN - SCOPUS:84894499797

VL - 41

SP - 51

EP - 57

JO - Undersea and Hyperbaric Medicine

JF - Undersea and Hyperbaric Medicine

SN - 1066-2936

IS - 1

ER -